These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7410849)

  • 1. Naturally occurring antibodies directed to TNBS-modified cell surface but not the trinitrophenyl moiety.
    Ballas ZK; Kuppers RC
    J Immunol; 1980 Oct; 125(4):1644-9. PubMed ID: 7410849
    [No Abstract]   [Full Text] [Related]  

  • 2. Generation of H-2 restricted cytotoxic T cells by trinitrophenylated proteins in vitro: specificity and requirements.
    Ballas ZK; Henney CS
    J Immunol; 1979 Oct; 123(4):1696-704. PubMed ID: 90099
    [No Abstract]   [Full Text] [Related]  

  • 3. Limitations of recognition of modified-self by alloantigen-activated cytotoxic T lymphocytes.
    Ballas ZK
    J Immunol; 1981 Oct; 127(4):1589-91. PubMed ID: 6168697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell-mediated cytotoxicity against trinitrophenyl-modified cells: effect of glutaraldehyde treatment on the immunogenicity and antigenicity of trinitrophenyl-modified cells.
    Forman J
    J Immunol; 1977 May; 118(5):1755-62. PubMed ID: 404357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cells treated with trinitrobenzene sulfonic acid express an antigenic determinant recognized by cytotoxic effector cells that is not detected on cells coated with trinitrophenylated proteins.
    Ciavarra R; Forman J
    J Immunol; 1980 Feb; 124(2):713-8. PubMed ID: 6153204
    [No Abstract]   [Full Text] [Related]  

  • 6. Relationship between trinitrophenol and H-2 antigens on trinitrophenyl-modified spleen cells. III. Quantitative aspects of trinitrophenol binding on cells treated with trinitrobenzene sulfonic acid.
    Vitetta ES; Hart DA; Forman J
    J Immunol; 1978 Sep; 121(3):997-1001. PubMed ID: 690447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-hapten antibody in primary immune antiserum can specifically inhibit antibody-secreting cells.
    Woodland RT; Zimmerman DM; Schrater AF
    J Immunol; 1982 Nov; 129(5):2009-15. PubMed ID: 6749983
    [No Abstract]   [Full Text] [Related]  

  • 8. Expression of both I-A and I-E/C subregion antigens on accessory cells required for in vitro generation of cytotoxic T lymphocytes against alloantigens or TNBS-modified syngeneic cells.
    Pettinelli CB; Ahmann GB; Shearer GM
    J Immunol; 1980 Apr; 124(4):1911-6. PubMed ID: 6154084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on natural killer (NK) cells. I. NK cell specific antibodies in CE anti-CBA serum.
    Burton RC; Winn HJ
    J Immunol; 1981 May; 126(5):1985-9. PubMed ID: 7217676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific helper T cells permit differentiation of thymic anti-self-trinitrophenyl cytotoxic precursor cells.
    Cooley MA; Schmitt-Verhulst AM
    J Immunol; 1979 Nov; 123(5):2328-36. PubMed ID: 314960
    [No Abstract]   [Full Text] [Related]  

  • 11. Natural and reinforced immunity against hapten-modified cells in vivo: importance of serum-borne and cellular factors.
    Bischoff P; Maugras M; Ferry F; Oth D
    Ann Immunol (Paris); 1982; 133D(3):281-91. PubMed ID: 7165279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on in vivo priming to TNP-reactive cytotoxic effector cell system. II. Augmented secondary cytotoxic response by radioresistant T cells and demonstration of differential helper activity as a function of the stimulating dose of TNP-self.
    Fujiwara H; Shearer GM
    J Immunol; 1980 Mar; 124(3):1271-6. PubMed ID: 6965689
    [No Abstract]   [Full Text] [Related]  

  • 13. The immune response against hapten-autologous protein conjugates in the mouse. I. Specificity of antibodies produced during the primary response against dinitrophenylated mouse serum albumin.
    Rubin B
    Eur J Immunol; 1973 Jan; 3(1):26-32. PubMed ID: 4123957
    [No Abstract]   [Full Text] [Related]  

  • 14. Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance.
    Elson CO; Beagley KW; Sharmanov AT; Fujihashi K; Kiyono H; Tennyson GS; Cong Y; Black CA; Ridwan BW; McGhee JR
    J Immunol; 1996 Sep; 157(5):2174-85. PubMed ID: 8757344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural antibodies to interferon-alpha and interferon-beta are a common feature of inbred mouse strains.
    De Maeyer-Guignard J; De Maeyer E
    J Immunol; 1986 Mar; 136(5):1708-11. PubMed ID: 3950401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of anti-mouse IgG on some complement-requiring alloantibodies of the mouse.
    Harris TN; Harris S
    J Immunol; 1972 Nov; 109(5):1096-108. PubMed ID: 4627933
    [No Abstract]   [Full Text] [Related]  

  • 17. Functional analysis of H-2-linked genetic control of immune responsiveness to TNP-MSA.
    Urba WJ; Hildemann WH
    J Immunol; 1979 Jul; 123(1):209-15. PubMed ID: 448148
    [No Abstract]   [Full Text] [Related]  

  • 18. Cell-surface antigenic modifications with trinitrophenyl sulfonate versus trifluoromethyl-dinitrophenyl sulfonate.
    Bischoff P; Maugras M; Llorens MC; Oth D
    Immunobiology; 1983 Feb; 164(1):1-12. PubMed ID: 6189780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of hapten-specific immunological tolerance and immunity in B lymphocytes. VII. Correlation between trinitrobenzenesulfonic acid administration, serum trinitrophenyl content, and level of tolerance.
    Fidler JM
    Cell Immunol; 1985 Aug; 94(1):285-91. PubMed ID: 3874706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Selective inactivation of specific T-suppressors immune to H-2 complex antigens and prevention of their generation in vivo by antisuppressor xenogenic antibodies].
    Abronina IF; Brondz BD; Suslov AP; Zaitseva MB; Karaulov AV
    Mol Biol (Mosk); 1981; 15(5):1131-43. PubMed ID: 6457978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.